Human Mobility and the Global Spread of Infectious Diseases: A Focus on Air Travel

Trends in Parasitology

Volumn 34, Issue 9, 2018, Pages 772-783

  Findlater, Aidan ^a   Bogoch, Isaac I ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

air travel; arbovirus; flight; infection; public health; surveillance

Indexed keywords

AEDES; ANTIBIOTIC RESISTANCE; ARBOVIRUS; AVIATION; CHIKUNGUNYA VIRUS; DENGUE VIRUS; DISEASE CARRIER; DISEASE TRANSMISSION; EBOLAVIRUS; ENDEMIC DISEASE; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; GLOBAL HEALTH; HUMAN; INFECTION; INFLUENZA; LOW INCOME COUNTRY; MALARIA; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE INCOME COUNTRY; MIGRANT; MIGRATION; PANDEMIC; PHYSICAL MOBILITY; PUBLIC HEALTH; REFUGEE; REVIEW; SCHISTOSOMIASIS; SEVERE ACUTE RESPIRATORY SYNDROME; TOURISM; TRAVEL RELATED DISEASE; ZIKA VIRUS; COMMUNICABLE DISEASE; THEORETICAL MODEL; TRANSMISSION;

AIR TRAVEL; COMMUNICABLE DISEASES; GLOBAL HEALTH; HUMANS; MODELS, THEORETICAL;

EID: 85050206554     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2018.07.004     Document Type: Review

References (121)

1. Tatem, A.J., et al. Global transport networks and infectious disease spread. Adv. Parasitol. 62 (2006), 293–343.
2. UN World Tourism Organization, UNWTO Tourism Highlights. 2017 edition, 2017, United Nations.
3. United Nations, Department of Economic and Social Affairs, Population Division, International Migration Report 2017: Highlights., 2017, United Nations.
4. Institute of Shipping Economics and Logistics (2017) World Seaborne Trade and World Port Traffic. Shipping Statistics and Market Review 61.
5. International Air Transport Association, IATA Annual Review 2017. 2017, IATA.
6. Haas, W.H., et al. Imported Lassa fever in Germany: surveillance and management of contact persons. Clin. Infect. Dis. 36 (2003), 1254–1258.
7. Angelini, R., et al. An outbreak of chikungunya fever in the province of Ravenna, Italy. Euro Surveill. 12 (2007), 12–14.
8. Khan, K., et al. Assessing the origin of and potential for international spread of chikungunya virus from the Caribbean. PLoS Curr. 6 (2014), 1–11.
9. Kraemer, M.U.G., et al. The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus. eLife, 4, 2015, e08347.
10. Leder, K., et al. GeoSentinel surveillance of illness in returned travelers, 2007–2011. Ann. Intern. Med. 158 (2013), 456–468.
11. Sinka, M.E., et al. A global map of dominant malaria vectors. Parasit. Vectors, 5, 2012, 69.
12. Boggild, A.K., et al. Travel-acquired infections and illnesses in Canadians: surveillance report from CanTravNet surveillance data, 2009-2011. Open Med. 8 (2014), e20–e32.
13. McCarthy, A.E., et al. Severe malaria in Canada, 2001–2013. Malar. J., 14, 2015, 151.
14. Isaäcson, M., Airport malaria: a review. Bull. World Health Organ. 67 (1989), 737–743.
15. Tatem, A.J., et al. Estimating the malaria risk of African mosquito movement by air travel. Malar. J., 5, 2006, 57.
16. Pomares-Estran, C., et al. Atypical aetiology of a conjugal fever: autochthonous airport malaria between Paris and French Riviera: a case report. Malar. J., 8, 2009, 202.
17. Wickremasinghe, A.R., et al. Should chemoprophylaxis be a main strategy for preventing re-introduction of malaria in highly receptive areas? Sri Lanka a case in point. Malar. J., 16, 2017, 102.
18. Imwong, M., et al. Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam. Lancet Infect. Dis. 17 (2017), 1022–1023.
19. Ouma, J.H., et al. Morbidity in schistosomiasis: an update. Trends Parasitol. 17 (2001), 117–118.
20. Ramalli, L., et al. Persistence of schistosomal transmission linked to the Cavu river in southern Corsica since 2013. Euro Surveill., 2018, 10.2807/1560-7917.ES.2018.23.4.18-00017 Published online 25 January 2018.
21. Hu, B., et al. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog., 13, 2017, e1006698.
22. Christian, M.D., et al. Severe acute respiratory syndrome. Clin. Infect. Dis. 38 (2004), 1420–1427.
23. Saywell, T., et al. The cost of SARS: $11 billion and rising. Dow Jones Far East. Econ. Rev. 166 (2003), 12–17.
24. Fidler, D.P., Gostin, L.O., The new International Health Regulations: an historic development for international law and public health. J. Law Med. Ethics 34 (2006), 85–94 4.
25. de Groot, R.J., et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J. Virol. 87 (2013), 7790–7792.
26. Yang, Y.-M., et al. Impact of comorbidity on fatality rate of patients with Middle East Respiratory Syndrome. Sci. Rep., 7, 2017, 11307.
27. Ki, M., 2015 MERS outbreak in Korea: hospital-to-hospital transmission. Epidemiol. Health, 37, 2015, e2015033.
28. Lee, S.S., Wong, N.S., Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea. Int. J. Infect. Dis. 38 (2015), 65–67.
29. Kucharski, A.J., Althaus, C.L., The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission. Euro Surveill. 20 (2015), 14–18.
30. Gardner, L.M., et al. Risk of global spread of Middle East respiratory syndrome coronavirus (MERS-CoV) via the air transport network. J. Travel Med. 23 (2016), 1–8.
31. Zumla, A., et al. Infectious diseases epidemic threats and mass gatherings: Refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV). BMC Med. 14 (2016), 2012–2015.
32. Leendertz, S.A.J., et al. Assessing the evidence supporting fruit bats as the primary reservoirs for Ebola viruses. Ecohealth 13 (2016), 18–25.
33. Lefebvre, A., et al. Case fatality rates of Ebola virus diseases: a meta-analysis of World Health Organization data. Med. Mal. Infect. 44 (2014), 412–416.
34. Regan, J.J., et al. Public health response to commercial airline travel of a person with Ebola virus infection – United States, 2014. MMWR Morb. Mortal. Wkly. Rep. 64 (2015), 63–66.
35. Bertoli, G., et al. Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. J. Infect. Dev. Ctries. 10 (2016), 537–543.
36. Lópaz, M.A., et al. First secondary case of Ebola outside Africa: epidemiological characteristics and contact monitoring, Spain, September to November 2014. Euro Surveill., 20, 2015, 21003.
37. Shuaib, F., et al. Ebola virus disease outbreak – Nigeria, July–September 2014. MMWR Morb. Mortal. Wkly. Rep. 63 (2014), 867–872.
38. Harris, M., et al. It takes threat of Ebola to see lessons from low income countries. Global Health, 11, 2015, 16.
39. Cohen, N.J., Travel and border health measures to prevent the international spread of Ebola. MMWR 65:Suppl (2016), 57–67.
40. BBC News (2014) Ivorian land border shut over Ebola. BBC News 23 August 2014.
41. CBC News (2014) Canada won't issue visas to residents of Ebola outbreak countries. CBC News 21 October 2014.
42. Iuliano, A.D., et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391 (2018), 1285–1300.
43. Johnson, N.P.A.S., Mueller, J., Updating the accounts: global mortality of the 1918–1920 ‘Spanish’ influenza pandemic. Bull. Hist. Med. 76 (2002), 105–115.
44. Grais, R.F., et al. Modeling the spread of annual influenza epidemics in the U.S.: the potential role of air travel. Health Care Manag. Sci. 7 (2004), 127–134.
45. Brownstein, J.S., et al. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med., 3, 2006, e401.
46. Rvachev, L.A., Longini, I.M., A mathematical model for the global spread of influenza. Math. Biosci. 75 (1985), 3–22.
47. Flahault, A., et al. A mathematical model for the European spread of influenza. Eur. J. Epidemiol. 10 (1994), 471–474.
48. Mena, I., et al. Origins of the 2009 H1N1 influenza pandemic in swine in Mexico. eLife, 5, 2016, e16777.
49. Khan, K., et al. Spread of a novel influenza A (H1N1) virus via global airline transportation. N. Engl. J. Med. 361 (2009), 212–214.
50. Simonsen, L., et al. Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study. PLoS Med., 10, 2013, e1001558.
51. Bonizzoni, M., et al. The invasive mosquito species Aedes albopictus: current knowledge and future perspectives. Trends Parasitol. 29 (2013), 460–468.
52. Brown, J.E., et al. Human impacts have shaped historical and recent evolution in Aedes aegypti, the dengue and yellow fever mosquito. Evolution 68 (2014), 514–525.
53. Brady, O.J., et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl. Trop. Dis., 6, 2012, e1760.
54. Thomas, L., et al. Clinical presentation of dengue by serotype and year of epidemic in Martinique. Am. J. Trop. Med. Hyg. 91 (2014), 138–145.
55. Gubler, D.J., Dengue, urbanization and globalization: the unholy trinity of the 21st century. Trop. Med. Health 39 (2011), 3–11.
56. Wilder-Smith, A., Gubler, D.J., Geographic expansion of dengue: the impact of international travel. Med. Clin. North Am. 92 (2008), 1377–1390.
57. Rezza, G., Dengue and chikungunya: long-distance spread and outbreaks in naïve areas. Pathog. Glob. Health 108 (2014), 349–355.
58. Bouri, N., et al. Return of epidemic dengue in the United States: implications for the public health practitioner. Public Health Rep. 127 (2012), 259–266.
59. Schaffner, F., Mathis, A., Dengue and dengue vectors in the WHO European region: past, present, and scenarios for the future. Lancet Infect. Dis. 14 (2014), 1271–1280.
60. Tomasello, D., Schlagenhauf, P., Chikungunya and dengue autochthonous cases in Europe, 2007-2012. Travel Med. Infect. Dis. 11 (2013), 274–284.
61. Tian, H., et al. Increasing airline travel may facilitate co-circulation of multiple dengue virus serotypes in Asia. PLoS Negl. Trop. Dis., 11, 2017, e0005694.
62. Nunes, M.R.T., et al. Air travel is associated with intracontinental spread of dengue virus serotypes 1–3 in Brazil. PLoS Negl. Trop. Dis., 8, 2014, e2769.
63. Duong, V., et al. Asymptomatic humans transmit dengue virus to mosquitoes. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 14688–14693.
64. Ten Bosch, Q.A., et al. Contributions from the silent majority dominate dengue virus transmission. PLoS Pathog., 14, 2018, e1006965.
65. Santé publique France (2017) Chikungunya, dengue et zika – Données de la surveillance renforcée en France métropolitaine en 2017. Santé publique France.
66. Venturi, G., et al. Detection of a chikungunya outbreak in Central Italy, August to September 2017. Euro Surveill., 22, 2017 17-00646.
67. Yactayo, S., et al. Epidemiology of Chikungunya in the Americas. J. Infect. Dis. 214 (2016), S441–S445.
68. Center for Disease Control and Prevention, Chikungunya: 2014 Final Data for the United States. 2015, Center for Disease Control and Prevention.
69. Duffy, M.R., et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 360 (2009), 2536–2543.
70. Rasmussen, S.A., et al. Zika virus and birth defects – reviewing the evidence for causality. N. Engl. J. Med. 374 (2016), 1981–1987.
71. Faria, N.R., et al. Zika virus in the Americas: Early epidemiological and genetic findings. Science 352 (2016), 345–349.
72. Bogoch, I.I., et al. Anticipating the international spread of Zika virus from Brazil. Lancet 387 (2016), 335–336.
73. Bogoch, I.I., et al. Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: a modelling study. Lancet Infect. Dis. 16 (2016), 1237–1245.
74. Kraemer, M.U.G., et al. Zika virus transmission in Angola and the potential for further spread to other African settings. Trans. R. Soc. Trop. Med. Hyg. 111 (2017), 527–529.
75. Siedner, M.J., et al. Gone or forgotten? The rise and fall of Zika virus. Lancet Public Health 3 (2018), e109–e110.
76. Plough, H.H., Penicillin resistance of Staphylococcus aureus and its clinical implications. Am. J. Clin. Pathol. 15 (1945), 446–451.
77. Cosgrove, S.E., Carmeli, Y., The impact of antimicrobial resistance on health and economic outcomes. Clin. Infect. Dis. 36 (2003), 1433–1437.
78. Adeyi, O.O., et al. Drug-Resistant Infections: A Threat to Our Economic Future. vol. 2: Final Report (English)., 2017, World Bank Group.
79. Molton, J.S., et al. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin. Infect. Dis. 56 (2013), 1310–1318.
80. Bonnet, R., Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48 (2004), 1–14.
81. Nordmann, P., et al. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17 (2011), 1791–1798.
82. Arcilla, M.S., et al. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect. Dis. 17 (2017), 78–85.
83. Kumarasamy, K.K., et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10 (2010), 597–602.
84. Yong, D., et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53 (2009), 5046–5054.
85. Berrazeg, M., et al. New Delhi Metallo-beta-lactamase around the world: an eReview using Google Maps. Euro Surveill., 19, 2014, 20809.
86. Payne, M., et al. mcr-1-Positive colistin-resistant Escherichia coli in traveler returning to Canada from China. Emerg. Infect. Dis. 22 (2016), 1673–1675.
87. Schwarz, S., Johnson, A.P., Transferable resistance to colistin: a new but old threat. J. Antimicrob. Chemother. 71 (2016), 2066–2070.
88. Bernasconi, O.J., et al. Travelers can import colistin-resistant enterobacteriaceae, including those possessing the plasmid-mediated mcr-1 gene. Antimicrob. Agents Chemother. 60 (2016), 5080–5084.
89. Ellem, J.A., et al. Locally acquired mcr-1 in Escherichia coli, Australia, 2011 and 2013. Emerg. Infect. Dis. 23 (2017), 1160–1163.
90. World Health Organization, Global Action Plan on Antimicrobial Resistance. 2015, World Health Organization.
91. Cowling, B.J., et al. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill. 20 (2015), 7–13.
92. Yu, V.L., Madoff, L.C., ProMED-mail: An early warning system for emerging diseases. Clin. Infect. Dis. 39 (2004), 227–232.
93. Freifeld, C.C., et al. HealthMap: global infectious disease monitoring through automated classification and visualization of Internet media reports. J. Am. Med. Inform. Assoc. 15 (2008), 150–157.
94. Mejia, R., Nutman, T.B., Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr. Opin. Infect. Dis. 25 (2012), 458–463.
95. Boggild, A.K., et al. CATMAT statement on disseminated strongyloidiasis: prevention, assessment and management guidelines. Can. Commun. Dis. Rep., 42, 2016, 12.
96. World Health Organization, Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early Implementation 2016–2017., 2017, World Health Organization.
97. Tambo, E., et al. Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries. Infect. Dis. Poverty, 3, 2014, 29.
98. Wang, Y.A., Barry, M., Making online outbreak surveillance work for all. Ann. Glob. Health 83 (2017), 625–629.
99. Dion, M., et al. Big data and the global public health intelligence network (GPHIN). Can. Commun. Dis. Rep., 41, 2015, 209.
100. Esposito, D.H., et al. Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011–2012. Clin. Infect. Dis. 59 (2014), 1401–1410.
101. Schwartz, E., et al. Detection on four continents of dengue fever cases related to an ongoing outbreak in Luanda, Angola, March to May 2013. Euro Surveill., 18, 2013, 20488.
102. Leder, K., et al. Zika beyond the Americas: Travelers as sentinels of Zika virus transmission. A GeoSentinel analysis, 2012 to 2016. PLoS One, 12, 2017, e0185689.
103. Bajardi, P., et al. Human mobility networks, travel restrictions, and the global spread of 2009 H1N1 pandemic. PLoS One, 6, 2011, e16591.
104. Aledort, J.E., et al. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health, 7, 2007, 208.
105. Chong, K.C., Ying Zee, B.C., Modeling the impact of air, sea, and land travel restrictions supplemented by other interventions on the emergence of a new influenza pandemic virus. BMC Infect. Dis., 12, 2012, 309.
106. Bogoch, I.I., et al. Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak. Lancet 385 (2015), 29–35.
107. World Bank, The Economic Impact of the 2014 Ebola Epidemic: Short and Medium Term Estimates for West Africa. 2014, World Bank.
108. Pattani, R., Unsanctioned travel restrictions related to Ebola unravel the global social contract. CMAJ 187 (2015), 166–167.
109. Gostic, K.M., et al. Effectiveness of traveller screening for emerging pathogens is shaped by epidemiology and natural history of infection. eLife, 4, 2015, e05564.
110. Hay, S.I., et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2017), 1260–1344.
111. Alemnji, G.A., et al. Strengthening national health laboratories in sub-Saharan Africa: a decade of remarkable progress. Trop. Med. Int. Health 19 (2014), 450–458.
112. Wertheim, H.F.L., et al. Laboratory capacity building in Asia for infectious disease research: experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN). PLoS Med., 7, 2010, e1000231.
113. Zumla, A., et al. Zika virus outbreak and the case for building effective and sustainable rapid diagnostics laboratory capacity globally. Int. J. Infect. Dis. 45 (2016), 92–94.
114. Hotez, P.J., et al. New vaccines for the world's poorest people. Annu. Rev. Med. 67 (2016), 405–417.
115. Bogoch, I.I., et al. Potential plague exportation from Madagascar via international air travel. Lancet Infect. Dis. 18 (2018), 247–248.
116. World Health Organization, Revamp of the Plague Detection in Madagascar Yields Quick and Sustainable Wins. 2018, World Health Organization.
117. Chin, C.-S., et al. The origin of the Haitian cholera outbreak strain. N. Engl. J. Med. 364 (2011), 33–42.
118. Liu, Y.-Y., et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16 (2016), 161–168.
119. Mackay, I.M., Arden, K.E., MERS coronavirus: diagnostics, epidemiology and transmission. Virol. J., 12, 2015, 222.
120. Pan American Health Organization, Number of Reported Cases of Chikungunya Fever in the Americas – EW 51 (December 22, 2017)., 2017, Pan American Health Organization.
121. Leparc-Goffart, I., et al. Chikungunya in the Americas. Lancet, 383, 2014, 514.